JakobGubenšek SloveniaUniversity Medical Center Ljubljana, Slovenia

I graduated from University of Ljubljana Medical School in 2002 and received my PhD in 2006 (thesis "Regional citrate anticoagulation during hemodialysis"). I finished residency in Internal medicine and Nephrology. Currently I am associate professor at Faculty of Medicine, University of Ljubljana and head of Center for Acute and Complicated Dialysis and Vascular Access at Department of Nephrology, University Medical Center Ljubljana, Ljubljana, Slovenia. I am involved in clinical work and research mainly in the fields of acute and chronic hemodialysis, apheresis, interventional nephrology, ultrasonography and vascular access surgery. My current clinical and research focus is vascular access surgery and ultrasonography. I published almost 60 articles in SCI journals and I am editorial board member at BMC Nephrology.

Institution

Day 1 - Sunday April 14, 2024

Time	Session

9 a.m. 10:30 a.m.	Innovations in Transplantation CHAL01 Gervasio Soler-Pujol Chairperson gsolerpujol@gmail.comMD MarioSchiffer Chairperson mario.schiffer@uk-erlangen.deGermanyUniversity hospital Erlangen Update in Robotic Kidney Transplantation RajeshSivaprakasam Speaker United Kingdom Progress in Xenotransplantation MeganSykes Speaker ms3976@cumc.columbia.eduUnited States Antigen-specific Chimeric Antigen Receptor Regulatory T Cells for Use in Solid Organ Transplantation CarolineLamarche Speaker caroline.lamarche.1@umontreal.caCanadaUniversité de Montréal Post Transplant TMA-pathogenesis and Management LilianMonteiro P. Palma Speaker lilian.palma@icloud.comBrazilState University of Campinas Q and A Hall A
10:30 a.m. 11 a.m.	Hitting the Four Hits: The Potential of Dual BAFF/APRIL Inhibition in IgA Nephropathy SPOT-O3 JonathanBarratt Spotlight Speaker United KingdomUniversity of Leicester, Leicester, UK Spotlight Stage 1 (exhibition hall)
11 a.m. 12 p.m.	Plenary Session 2: CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria) PL2 AgnesFogo Chairperson United States GuillermoRosa Diez Chairperson guillermo.rosadiez@hospitalitaliano.org.arArgentinaHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of Nephrology My Story VictoriaGray Speaker vwright_03@yahoo.comUnited States CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture Obiageli EuniceNnodu Speaker oennodu@gmail.comNigeriaUniversity of Abuja Hall A
12:15 p.m. 1:15 p.m.	The ISN Emerging Leaders and Environmentally Sustainable Kidney Care: The Time is Now BKH1001 LetiziaDe Chiara Chairperson letizia.dechiara@unifi.itItalyDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence MariaPippias Chairperson United KingdomUniversity of Bristol Introducing CarolineStigant Speaker Caroline.Stigant@islandhealth.caCanada The Impact of Kidney Care on the Environment and the EhabHafiz Speaker EgyptTheodor Bilharz Research Institute A New Armamentarium to Fight Climate Change: How to Apply the ISN Green Nephrology Toolkit Winston Wing ShingFung Speaker Hong Kong, ChinaPrince of Wales Hospital, Hong Kong Q and A Hall D
3 p.m. 4 p.m.	A Balancing Act: Your Kidneys and Electrolytes LF1007 Angela Yee-MoonWang Chairperson SingaporeHong Kong/Singapore ThiagoDe Azevedo Reis Chairperson thiagoreisnefro@gmail.comBrazilHospital Sírio-Libanês, São Paulo, Brazil & Fenix Is Magnesium a Missing Puzzle for Vascular Calcification in CKD? SolaAoun Bahous Speaker sola.bahous@gmail.comLebanonLebanese American University School of Medicine Should Potassium Be Restricted or Not in CKD? RobertoPecoits Filho Speaker United StatesArbor Research Collaborative for Health Metabolic Acidosis in CKD: When to Treat? What to Target? MitchellRosner Speaker United StatesUniveristy of Virginia Health Q and A Hall A	Meeting Interventional Nephrology Needs in Low Resource Settings BKH1006 JadrankaButurović Ponikvar Chairperson SloveniaUniversity Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Slovenia RodrigoCampos Chairperson rpeixotocampos@gmail.comBrazilFundação Pró-Renal, Curitiba Mexico as a Training Hub for Interventional Nephrology in Latin America BernardoMoguel González Speaker bernardomoguel@hotmail.comMexicoInstituto Nacional de Cardiologia Ignacio Chavez Mexico city Interventional Nephrology in Cameroon NzanaVictorine Bandolo Speaker CameroonFaculty of Medicine and Biomedical Sciences (FMBS) How to Organize an Interventional Nephrology Program Adapted to Regional Resources TusharVachharajani Speaker United StatesJohn D. Dingell Veterans Affairs Medical Center / Wayne State University School of Medicine Q and A Hall C3
4:30 p.m. 5:30 p.m.	Building Competency in Nephrology Education BKH1004 Augusto CesarSoares dos Santos Junior Chairperson BrazilHospital das Clinicas, UFMG; Fac Ciências Medicas Li-LiHsiao Chairperson lhsiao@bwh.harvard.eduUnited StatesBrigham and Women\'s Hospital, Harvard Medical School Curriculum Design to Developing Competency in Nephrology Practice ReneScalet Dos Santos Neto Speaker renesantosneto@gmail.comBrazilFaculdades Pequeno Principe (FPP) - Brazil Developing Clinical Reasoning KarenWarburton Speaker KMW2G@uvahealth.orgUnited StatesUniversity of Virginia Health System Assessment of Nephrology Trainees to Ensure Competence SolaAoun Bahous Speaker sola.bahous@gmail.comLebanonLebanese American University School of Medicine Q and A Hall C2

Day 2 - Monday April 15, 2024

Time	Session

9 a.m. 10:30 a.m.	ADPKD Updates LF04 CarlosDiaz Chairperson cdiaz@cemic.edu.arArgentinaSección Nefrología, Departamento de Medicina Interna, Instituto Universitario CEMIC. CristianKramer Chairperson cristiankramer@yahoo.esArgentinahosptial ramos mejìa Role of Genetic Testing in ADPKD PeterHarris Speaker harris.peter@mayo.eduUnited StatesMayo Clinic New Metabolic Pathways Driving PKD Progression AlessandraBoletta Speaker boletta.alessandra@hsr.itItalySan Raffaele Scientific Institute ADPKD Management Guidelines AlfredoWassermann Speaker awasser@gmail.comArgentinaFEPREVA The Future Landscape for ADPKD Treatment VicenteTorres Speaker United StatesMayo Clinic Q and A Hall C1	Editors' Pick of ISN Journals: KI and KIR KI GermaineWong Chairperson AustraliaUniversity of Sydney PierreRonco Chairperson FranceHôpital Tenon KI Highlights PierreRonco Speaker FranceHôpital Tenon KI Highlights 1 Eugene Yu HinChan Speaker Hong Kong, ChinaThe Chinese University of Hong Kong, Hong Kong Children's Hospital KI Highlights 2 MuzamilHassan Speaker NigeriaDepartment of Medicine, Obafemi Awolowo University, Ile-Ife, Nigeria KI Highlights 3 VeronicaMiguel Speaker SpainSpanish National Centre for Cardiovascular Research KI Highlights 4 GriffithPerkins Speaker Australia KIR - Update JaiRadhakrishnan Speaker United StatesColumbia University in the City of New York KIR Highlights 1 SumitMohan Speaker United StatesColumbia University KIR Highlights 2 AndreaViecelli Speaker AustraliaUniversity of Queensland Presentation of Best Reviewer Awards BradRovin Speaker United StatesThe Ohio State University Presentation of Basic Science Awards (Early Career Researchers Awards) ChristophKuppe Speaker GermanyDepartment of Nephrology, RWTH University Aachen, Germany Presentation of Clinical Science Awards (Early Career Researchers Awards) IsabelleAyoub Speaker United StatesThe Ohio State University Q and A BradRovin Speaker United StatesThe Ohio State University Hall C2
11 a.m. 12 p.m.	Plenary Session 3: Generative AI Revolution in Medicine (Michal Rosen-Zvi, Israel) PL3 Jose VicenteSanchez Polo Chairperson visanpolo@gmail.comGuatemalaRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH) MegJardine Chairperson AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia Generative AI Revolution in Medicine MichalRosen-Zvi Speaker ROSEN@il.ibm.comIsraelhttps://research.ibm.com/ Acceptance Speech by Awardee (Schrier Award), with Tasnuva Sarah Kashem (UK) and Farnaz Nobi (Bangladesh) Mohammad Shakib Uz ZamanArefin Speaker shakib04@yahoo.comBangladesh Hall A
12:15 p.m. 1:15 p.m.	Digging Up the Ethical Foundations of Kidney Care BKH1005 DominiqueMartin Chairperson AustraliaDeakin University FergusCaskey Chairperson United KingdomUniversity of Bristol, UK Supported Decision-making and Its Relevance to Kidney Care Barbara Finn Speaker bfinn@hbritanico.com.arArgentina Decision-making in Prenatal Kidney Care: Why Ethics Needs Evidence Omri DavidSoffer Speaker David.Soffer@unmc.eduUnited StatesUniversity of Nebraska Medical Center/ Children's Understanding Cultural Safety in Kidney Care CarolineTait Speaker Canada Q and A Hall C2	KDIGO 2024 Anemia Guideline: Case-based Illustrations: ISN-KDIGO Joint Session LF1003 Carlos LuisBlanco Chairperson clbblanco@yahoo.com.arArgentinaCARLOS LUIS BLANCO, ISN EMERIT MEMBER, ARGENTINA MarcelloTonelli Chairperson CanadaUniversity of Calgary TalerngsakKanjanabuch Chairperson ThailandFaculty of Medicine, Chulalongkorn University KDIGO 2024 Anemia CKD Guideline: Overview on Methodology and Key Guidance EviNagler Speaker BelgiumNephrology Department, Ghent University Hospital, Practical Guideline Applications for Patients with Anemia CKD Not on Dialysis JoséA. Moura-Neto Speaker jamouraneto@hotmail.comBrazilBrazilian Society of Nephrology Practical Guideline Applications for Select Patients With Anemia: Dialysis, Kidney Transplant Recipients, and Children with CKD MarcelloTonelli Speaker CanadaUniversity of Calgary Q and A Hall E
3 p.m. 4 p.m.	Late Breaking Clinical Trials Session LBCT AlessiaFornoni Chairperson United StatesUniversity of Miami MichelleRheault Chairperson rheau002@umn.eduUnited StatesUniversity of Minnesota Predicting the Risks of Kidney Failure and Death in Adults With Moderate-to-severe Chronic Kidney Disease (KDpredict) PietroRavani Free Communication pravani@ucalgary.caCanadaUniversity of Calgary Plasma Exchange in ANCA Associated Vasculitis GN: Update After Pexivas Wladimir MietekSzpirt Speaker wladimir.mietek.szpirt.01@regionh.dkDenmarkRigshospitalet, University of Copenhagen, Dept. of Nephrology, Denmark, Senior Research Consultant EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY: INTERIM RESULTS FROM THE PHASE 3 APPLAUSE-IgAN STUDY DanaRizk Free Communication drizk@uabmc.eduUnited StatesUniversity of Alabama at Birmingham SPARSENTAN VS IRBESARTAN IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN): SUBGROUP ANALYSES OF 2-YEAR RESULTS FROM THE PIVOTAL PHASE 3 PROTECT TRIAL JonathanBarratt Free Communication United KingdomUniversity of Leicester, Leicester, UK PREGNANCY AMONG WOMEN ON CHRONIC DIALYSIS : THE FRENCH COHORT CécileCouchoud Free Communication cecile.couchoud@biomedecine.frFranceREIN registry, Agence de la biomédecine, France Hall A	Treatment Goals for Severe Hyponatremia: A Debate on Current Guidelines Program LF1005 MitchellRosner Chairperson United StatesUniveristy of Virginia Health Overview of Hyponatremia Angela Yee-MoonWang Speaker SingaporeHong Kong/Singapore Pro: Current Guidelines are Appropriate HelbertRondon-Berrios Speaker rondonberriosh@upmc.eduUnited StatesUniversity of Pittsburgh School of Medicine Con: Current Guidelines are Too Conservative CarlosAyus Speaker carlosayus@yahoo.comUnited StatesUniversity of California Irvine Discussion Hall C3
4:30 p.m. 5:30 p.m.	Personalized Kidney Replacement Treatment: Adapting Guidelines to Real-world Scenarios LF06 Annie-ClaireNadeau-Fredette Chairperson annieclairenaf@gmail.comCanadaUniversité de Montréal Gabriel NicolasContreras Martin Chairperson gcontrer@med.miami.eduUnited StatesUniversity of Miami Miller School of Medicine Maria ElenaBiain Chairperson mariaelenabiain@yahoo.com.arMédica Nefróloga The Who, What, Where, When and Why of Incremental Hemodialysis ConnieRhee Speaker crhee@mednet.ucla.eduUnited StatesUCLA The Changing Landscape of Home Hemodialysis: Is There a Right Patient for Home Hemodialysis? KarthikTennankore Speaker ktennankore@gmail.comCanadaNova Scotia Health/Dalhousie University Patient-, Center- and Country-related Risk Factors for Peritoneal Dialysis Attrition: Can We Prevent It? RosileneM Elias Speaker rosilenemotta@hotmail.comBrazilUniversidade de Sao Paulo Q and A Hall C4

Day 3 - Tuesday April 16, 2024

Time	Session

9 a.m. 10:30 a.m.	Hi Aldo, What's New? Advances in Aldosterone in Health and Disease IK04 CarlosSchreck Chairperson carlos.schreck@gmail.comArgentinaHospital Italiano de Buenos Aires- Nephrology KellyHaughton Chairperson kidneydoctorpanama@gmail.comPanamaSLANH, Panama Why Are Fewer Than I% Of Hypertensive Patients Ever Screened For Primary Aldosteronism? John Funder Speaker John.Funder@hudson.org.auAustraliaThe Hudson Institute of Medical Research Clayton 3168 Victoria Australia; Monash University, Clayton 3600 Victoria Australia Aldosterone and Disease JordanaCohen Speaker jco@pennmedicine.upenn.eduUnited StatesUniversity of Pennsylvania New Trials Using Aldosterone Synthese Blockade MichelAzizi Speaker michel.azizi@aphp.frFranceUniversité Paris Cité, Hypertension department, Hô Targeting MR for Heart and Kidney Protection HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands Q and A Hall E
9 a.m. 10:30 a.m.	Clinical Management of Glomerulonephritis (GN) SK06 Juan ManuelMejia Vilet Chairperson jmmejia@hotmail.comMexicoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán ValeriaAlberton Chairperson vgalberton@gmail.comArgentinaHospital Fernandez/ Hospital El Cruce Updates on IgAN Management HernánTrimarchi Speaker ArgentinaHOSPITAL BRITÁNICO DE BUENOS AIRES Membranous GN Classification and Management PierreRonco Speaker FranceHôpital Tenon MPGN Updates SanjeevSethi Speaker United StatesMayo Clinic Managing Vasculitis RobertaFenoglio Speaker roberta.fenoglio@unito.itItalyOspedale San Giovanni Bosco Q and A Hall A
11 a.m. 12:15 p.m.	Plenary Session 4: Insights into SGLT2 Inhibitors: A Story of Discovery (Ele Ferrannini, Italy) PL4 AlessiaFornoni Chairperson United StatesUniversity of Miami LizLightstone Chairperson United KingdomImperial College London MasaomiNangaku Chairperson Japan Acceptance Speech: Bywaters Award MotokoYanagita Speaker JapanKyoto University Insights into SGLT2 Inhibitors: A Story of Discovery. Donald Seldin Lecture EleFerrannini Speaker eleferrannini@gmail.comItalyUniversity of Pisa ELP2 Graduation MasaomiNangaku Speaker Japan Hall A
12:30 p.m. 1:30 p.m.	Rare and Orphan Diseases SK07 AliGharavi Chairperson ag2239@cumc.columbia.eduUnited States RobertaFenoglio Chairperson roberta.fenoglio@unito.itItalyOspedale San Giovanni Bosco VaninaVazquez Chairperson azquezvanina64@gmail.comArgentina Alport Spectrum Disorders (Genetics) MoumitaBarua Speaker moumita.barua@uhn.caCanada Genetics of Nephrotic Syndrome SimoneSanna-Cherchi Speaker ss2517@cumc.columbia.eduUnited StatesColumbia University Lupus Nephritis Transcriptomics Across Time and Space AnaMalvar Speaker avmperrin@yahoo.com.arArgentinaHospotal Fernandez, Organizacion Medica de Investigacion Q and A Hall E

Pre-Congress - Saturday April 13, 2024

Time	Session

9 a.m. 11 a.m.	Interventional Nephrology Course: Catheters and Biopsy INTV1 AhmedSokwala Chairperson drsokwala@gmail.comKenyaAga Khan University Hospital Nairobi ArifAsif Chairperson arif.asif@hmhn.orgUnited States GriseldaBratti Chairperson griselda.bratti@hospitalitaliano.org.arArgentinaHospital Italiano of Buenos Aires. Argentina JadrankaButurović Ponikvar Chairperson SloveniaUniversity Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Slovenia Tunneled Hemodialysis Catheters OctavioSalgado Speaker ojsalg@hotmail.comEcuadorChair of Nephrology, School of Medicine, Universidad Católica de Cuenca, Ecuador. Insertion of PD Catheters BrettCullis Speaker South AfricaUniversity of Cape Town Biopsy of Native and Transplanted Kidney FedericoLevy Speaker levyfede@gmail.comArgentinaDr Hands-on Modules - HD Hands-on Modules - PD Hands-on Modules - Kidney Biopsy Hall D
11:30 a.m. 1:30 p.m.	Interventional Nephrology Course: Arteriovenous Access for Hemodialysis INTV2 AhmedSokwala Chairperson drsokwala@gmail.comKenyaAga Khan University Hospital Nairobi ArifAsif Chairperson arif.asif@hmhn.orgUnited States GriseldaBratti Chairperson griselda.bratti@hospitalitaliano.org.arArgentinaHospital Italiano of Buenos Aires. Argentina JadrankaButurović Ponikvar Chairperson SloveniaUniversity Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Slovenia Physical Evaluation of Arteriovenous Fistula JakobGubenšek Speaker jakob.gubensek@kclj.siSloveniaUniversity Medical Center Ljubljana, Slovenia Vascular Access Related Endovascular Procedures AnilAGARWAL Speaker United StatesUniversity of California San Francisco, Fresno, US Approach to Thrombosed Vascular Access ArifAsif Speaker arif.asif@hmhn.orgUnited States Hands-on Modules - Arteriovenous Fistula Hands-on Modules - Vascular Access Related Endovascular Procedures Hands-on Modules - Thrombosed Vascular Access Hall D
2:15 p.m. 4:15 p.m.	Interventional Nephrology Course: Ultrasonography for Nephrologists INTV3 AhmedSokwala Chairperson drsokwala@gmail.comKenyaAga Khan University Hospital Nairobi ArifAsif Chairperson arif.asif@hmhn.orgUnited States GriseldaBratti Chairperson griselda.bratti@hospitalitaliano.org.arArgentinaHospital Italiano of Buenos Aires. Argentina JadrankaButurović Ponikvar Chairperson SloveniaUniversity Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Slovenia Doppler Ultrasonography of Native and Transplanted Kidney JadrankaButurović Ponikvar Speaker SloveniaUniversity Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Slovenia Ultrasonography Volume Status Assessment (Lungs, IVC) and Limited Cardiac Echo SuryatiYakob Speaker suryatiyakob@gmail.comMalaysiaHospital Kuala Lumpur Ultrasonography Evaluation of Arteriovenous Fistula AhmedSokwala Speaker drsokwala@gmail.comKenyaAga Khan University Hospital Nairobi Hands-on Modules - Ultrasonography Volume Status Assessment (Lungs, IVC) and Limited Cardiac Echo Hands-on Modules - Doppler Ultrasonography of Native and Transplanted Kidney Hands-on Modules - Ultrasonography Evaluation of Arteriovenous Fistula Hall D
4:30 p.m. 6 p.m.	WCN'24 Opening Ceremony and Plenary Session 1: The Origin of the Universe (Daniel de Florian, Argentina) OCPL1 ISN President's Address MasaomiNangaku Speaker Japan Tribute to Stewart Cameron Welcome by WHO Director of Non-Communicable Diseases Dr Bente Mikkelsen Welcome by Dr. Marina Papaginovic, SAN President; Dr. Guillermo Rosa Diez, WCN Local Organising Group Chair; and Dr. Jorge Rico, SLANH President and WCN Local Organizing Group co-Chair GuillermoRosa Diez Speaker guillermo.rosadiez@hospitalitaliano.org.arArgentinaHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of Nephrology JorgeRico Speaker jorgericof@yahoo.comColombia MariaPapaginovic Leiva Speaker drapapaginovicleiva@gmail.comArgentina Welcome by Minister of Health for Buenos Aries Dr Fern Welcome by SPWG Chair Alessia Fornoni AlessiaFornoni Speaker United StatesUniversity of Miami The Origin of the Universe DanielDe Florian Speaker deflo@unsam.edu.arArgentinaUniversidad Nacional de San Martin Acceptance Speech: Hamburger Award AdeeraLevin Speaker CanadaUniversity of British Columbia and Providence Health Care Hall A